Earnings Scheduled For August 22, 2012

American Eagle Outfitters AEO is expected to report its Q2 earnings at $0.21 per share on revenue of $721.68 million. Hewlett-Packard Company HPQ is projected to post its Q3 EPS at $0.98 on revenue of $30.10 billion. Chico's FAS CHS is estimated to report its Q2 EPS at $0.30 on revenue of $641.26 million. Express EXPR is projected to report its Q2 earnings at $0.17 per share on revenue of $467.43 million. Toll Brothers TOL is estimated to report its Q3 EPS at $0.18 on revenue of $508.98 million. Pacific Sunwear of California PSUN is projected to post a Q2 loss at $0.12 per share on revenue of $203.17 million. Guess' GES is expected to post its Q2 earnings at $0.54 per share on revenue of $637.19 million. Synopsys SNPS is estimated to post its Q3 EPS at $0.50 on revenue of $443.94 million. China Cord Blood CO is projected to post its Q1 earnings at $0.04 per share on revenue of $16.23 million. Focus Media Holding Ltd FMCN is estimated to post its Q2 EPS at $0.59 on revenue of $225.98 million. Krispy Kreme Doughnuts KKD is projected to post its Q2 EPS at $0.05 on revenue of $103.74 million. Prospect Capital PSEC is estimated to post its Q4 earnings at $0.40 per share on revenue of $85.12 million. Vanguard Health Systems VHS is projected to post its Q4 EPS at $0.12 on revenue of $1.53 billion. HEICO HEI is expected to post its Q3 EPS at $0.41 on revenue of $232.25 million. The Hain Celestial Group HAIN is projected to post its Q4 EPS at $0.45 on revenue of $365.59 million. Semtech SMTC is estimated to post its Q2 EPS at $0.41 on revenue of $149.56 million. China Zenix Auto International Ltd ZX is expected to report its Q2 earnings. Eaton Vance EV is projected to report its Q3 earnings at $0.47 per share on revenue of $304.06 million. International Rectifier IRF is estimated to post a Q4 loss at $0.15 per share on revenue of $262.53 million. DFC Global DLLR is expected to post its Q4 EPS at $0.56 on revenue of $281.18 million. Delhaize Group DEG is estimated to report its Q2 earnings. China Nuokang Bio-Pharmaceutical NKBP is expected to post its Q2 earnings at $0.07 per share on revenue of $11.81 million.